Literature DB >> 6548616

Effect of ivermectin in heifers on mortality and egg production of Psoroptes ovis.

F C Wright, F S Guillot.   

Abstract

Ten stanchioned heifers, heavily infested with Psoroptes ovis (Hering), were each given a single subcutaneous injection of 200 micrograms of ivermectin/kg. Another 10 heavily infested heifers (stanchioned) were injected subcutaneously with the solvent system (vehicle) used to formulate the ivermectin. Treatment with the vehicle did not reduce mite populations or total egg counts. The 10 heifers treated with ivermectin had an immediate reduction in live mite and egg counts (an increase in the percentage of mortality of mites) and were completely free of psoroptic mites by 20 days after treatment. Ivermectin was equally effective against adult and immature psoroptic mites.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6548616

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  4 in total

1.  Treatment and control of bovine sarcoptic and psoroptic mange infestation with ivermectin long-acting injectable (IVOMEC(®) GOLD).

Authors:  Dietmar Hamel; Anja Joachim; Michael Löwenstein; Kurt Pfister; Cornelia Silaghi; Martin Visser; Renate Winter; Stephen Yoon; Luiz Cramer; Steffen Rehbein
Journal:  Parasitol Res       Date:  2014-11-18       Impact factor: 2.289

2.  A review of the pharmacology and clinical uses of ivermectin.

Authors:  T B Barragry
Journal:  Can Vet J       Date:  1987-08       Impact factor: 1.008

3.  Ultrastructural morphology of the male and female genital tracts of Psoroptes spp. (Acari: Astigmata: Psoroptidae).

Authors:  Mireille Lekimme; Michèle Leclercq-Smekens; Chantal Devignon; Thierry Leclipteux; Yves Poumay; Bertrand Losson
Journal:  Exp Appl Acarol       Date:  2005       Impact factor: 2.132

4.  Control of cattle mange in southern Africa using ivermectin.

Authors:  M D Soll; I H Carmichael; G E Swan; H Scherer
Journal:  Trop Anim Health Prod       Date:  1987-05       Impact factor: 1.559

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.